selected scholarly activity
-
conferences
- Diagnostic and Management Challenges with Multifocal Pheochromocytoma. Endocrine Reviews. 2014
-
journal articles
- Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial. The Lancet Respiratory Medicine. 10:1160-1168. 2022
- Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial. The Lancet Respiratory Medicine. 10:1169-1177. 2022
- MAiD to Last: Creating a Care Ecology for Sustainable Medical Assistance in Dying Services. HEC Forum. 34:409-428. 2022
- The Anti-Coronavirus Therapies (ACT) Trials: Design, Baseline Characteristics, and Challenges. CJC OPEN. 4:568-576. 2022
- Equity and Game-Theory Strategies to Promote Gender Diversity and Inclusion in an Academic Health Science Centre. CJC OPEN. 3:S53-S61. 2021
- Pharmacologic Management of Type 2 Diabetes: 2016 Interim Update. Canadian Journal of Diabetes. 40:193-195. 2016
- Cardiovascular and Other Outcomes Postintervention With Insulin Glargine and Omega-3 Fatty Acids (ORIGINALE). Diabetes Reviews. 39:709-716. 2016
- Addendum to Policies, Guidelines and Consensus Statements: Pharmacologic Management of Type 2 Diabetes: 2015 Interim Update. Canadian Journal of Diabetes. 39:440-440. 2015
- Policies, Guidelines and Consensus Statements: Pharmacologic Management of Type 2 Diabetes–2015 Interim Update. Canadian Journal of Diabetes. 39:250-252. 2015
- Long-Term Efficacy of Modified-Release Recombinant Human Thyrotropin Augmented Radioiodine Therapy for Benign Multinodular Goiter: Results from a Multicenter, International, Randomized, Placebo-Controlled, Dose-Selection Study. Thyroid. 24:727-735. 2014
- Dysfonction érectile. Canadian Journal of Diabetes. 37:S528-S530. 2013
- Pharmacothérapie du diabète de type 2. Canadian Journal of Diabetes. 37:S428-S436. 2013
- Erectile Dysfunction. Canadian Journal of Diabetes. 37:S150-S152. 2013
- Pharmacologic Management of Type 2 Diabetes. Canadian Journal of Diabetes. 37:S61-S68. 2013
- Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia. New England Journal of Medicine. 367:319-328. 2012
- n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia. New England Journal of Medicine. 367:309-318. 2012
- Randomized trial of insulin versus usual care in reducing restenosis after coronary intervention in patients with diabetes. the STent Restenosis And Metabolism (STREAM) study. Cardiovascular Revascularization Medicine. 13:95-100. 2012
- Modified-Release Recombinant Human TSH (MRrhTSH) Augments the Effect of131I Therapy in Benign Multinodular Goiter: Results from a Multicenter International, Randomized, Placebo-Controlled Study. Journal of Clinical Endocrinology and Metabolism (JCEM). 96:1368-1376. 2011
- Effects of Intensive Glucose Lowering in Type 2 Diabetes. New England Journal of Medicine. 358:2545-2559. 2008
- Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods. American Journal of Cardiology. 99:S21-S33. 2007
- Thiazolidinediones and Their Effect on Bone Metabolism: A Review. Canadian Journal of Diabetes. 31:378-383. 2007